Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Share-based Compensation (2018 - 2025)

AVITA Medical (RCEL) has disclosed Share-based Compensation for 7 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation fell 50.93% year-over-year to $1.4 million, compared with a TTM value of $9.5 million through Dec 2025, down 29.47%, and an annual FY2025 reading of $9.5 million, down 29.47% over the prior year.
  • Share-based Compensation was $1.4 million for Q4 2025 at AVITA Medical, down from $2.8 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.1 million in Q3 2024 and bottomed at $1.1 million in Q2 2023.
  • Average Share-based Compensation over 4 years is $2.5 million, with a median of $2.7 million recorded in 2023.
  • The sharpest move saw Share-based Compensation soared 252.32% in 2024, then plummeted 50.93% in 2025.
  • Year by year, Share-based Compensation stood at $1.2 million in 2022, then surged by 78.54% to $2.2 million in 2023, then grew by 28.88% to $2.8 million in 2024, then tumbled by 50.93% to $1.4 million in 2025.
  • Business Quant data shows Share-based Compensation for RCEL at $1.4 million in Q4 2025, $2.8 million in Q3 2025, and $2.7 million in Q2 2025.